#BEGIN_DRUGCARD DB02262

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
65-86-1

# ChEBI_ID:
16742

# Chemical_Formula:
C5H4N2O4

# Chemical_IUPAC_Name:
2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
-0.83

# Experimental_Logs:
-1.93

# Experimental_Water_Solubility:
1820 mg/L (at 18 °C)

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Orotic Acid

# HET_ID:
ORO

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)

# InChI_Key:
InChIKey=PXQPEWDEAKTCGB-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00295

# KEGG_Drug_ID:
D00055

# LIMS_Drug_ID:
2262

# Mechanism_Of_Action:
Not Available

# Melting_Point:
345.5 °C

# Molecular_Weight_Avg:
156.0963

# Molecular_Weight_Mono:
156.017106626

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1UUM

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.89

# Predicted_LogS:
-1.5

# Predicted_Water_Solubility:
4.51e+00 g/l

# Primary_Accession_No:
DB02262

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
967

# PubChem_Substance_ID:
46508903

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02447

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=CC(=O)NC(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:57 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AY323899

# Drug_Target_1_GenBank_ID_Protein:
33302311

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
pyrDA

# Drug_Target_1_Gene_Sequence:
>936 bp
ATGCTTAATACAACTTTTGCAAATGCCAAATTCGCTAATCCATTTATGAACGCTTCAGGA
GTCCATTGTATGACGATTGAGGATTTAGAAGAATTAAAAGCCTCTCAAGCAGGGGCCTAT
ATCACCAAAAGTTCCACATTAGAAAAAAGAGAAGGTAATCCACTCCCACGTTATGTTGAC
TTAGAATTAGGGTCAATTAATTCTATGGGTCTGCCTAATTTAGGATTTGATTACTACTTA
GACTATGTTTTAAAAAATCAAAAAGAAAATGCTCAAGAAGGGCCAATCTTCTTTTCCATT
GCGGGTATGAGTGCAGCAGAAAATATCGCTATGCTCAAGAAAATTCAAGAAAGTGATTTT
TCAGGAATTACAGAGTTGAATCTTTCTTGTCCAAATGTTCCTGGTAAACCACAACTTGCT
TATGATTTTGAAGCAACTGAAAAGCTCCTAAAAGAAGTTTTTACTTTCTTTACAAAACCG
CTAGGTGTCAAACTTCCCCCTTATTTTGACCTTGTACATTTTGATATTATGGCAGAAATC
CTCAATCAGTTTCCATTGACTTATGTGAATTCAGTGAATAGTATTGGAAATGGACTTTTT
ATTGACCCAGAAGCAGAAAGCGTAGTTATTAAGCCTAAAGATGGATTTGGTGGAATTGGT
GGAGCTTACATCAAACCAACAGCGCTTGCAAATGTCCGTGCTTTCTATACTCGACTCAAA
CCTGAAATTCAAATCATTGGAACAGGTGGGATTGAAACAGGACAAGATGCCTTTGAACAC
CTCTTATGTGGAGCTACAATGCTTCAAATTGGAACAGCTTTACACAAAGAAGGACCTGCA
ATCTTTGATAGAATCATTAAAGAATTAGAAGAAATAATGAATCAAAAAGGCTATCAATCA
ATTGCTGATTTCCATGGAAAATTAAAATCATTATAA

# Drug_Target_1_General_Function:
Nucleotide transport and metabolism

# Drug_Target_1_General_References:
9032071	Rowland P, Nielsen FS, Jensen KF, Larsen S: The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis. Structure. 1997 Feb 15;5(2):239-52.
9405053	Bjornberg O, Rowland P, Larsen S, Jensen KF: Active site of dihydroorotate dehydrogenase A from Lactococcus lactis investigated by chemical modification and mutagenesis. Biochemistry. 1997 Dec 23;36(51):16197-205.
9655329	Rowland P, Bjornberg O, Nielsen FS, Jensen KF, Larsen S: The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function. Protein Sci. 1998 Jun;7(6):1269-79.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3680

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34211

# Drug_Target_1_Name:
Dihydroorotate dehydrogenase A

# Drug_Target_1_Number_of_Residues:
311

# Drug_Target_1_PDB_ID:
1JUE

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01180	DHO_dh

# Drug_Target_1_Protein_Sequence:
>Dihydroorotate dehydrogenase A
MLNTTFANAKFANPFMNASGVHCMTIEDLEELKASQAGAYITKSSTLEKREGNPLPRYVD
LELGSINSMGLPNLGFDYYLDYVLKNQKENAQEGPIFFSIAGMSAAENIAMLKKIQESDF
SGITELNLSCPNVPGKPQLAYDFEATEKLLKEVFTFFTKPLGVKLPPYFDLVHFDIMAEI
LNQFPLTYVNSVNSIGNGLFIDPEAESVVIKPKDGFGGIGGAYIKPTALANVRAFYTRLK
PEIQIIGTGGIETGQDAFEHLLCGATMLQIGTALHKEGPAIFDRIIKELEEIMNQKGYQS
IADFHGKLKSL

# Drug_Target_1_Reaction:
(S)-dihydroorotate + O2 = orotate + H2O2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
(S)-dihydroorotate + O(2) = orotate + H(2)O(2)

# Drug_Target_1_SwissProt_ID:
Q53ZE5

# Drug_Target_1_SwissProt_Name:
PYRDA_LACLC

# Drug_Target_1_Synonyms:
DHOD A
DHODase A
DHOdehase A
Dihydroorotate oxidase A
EC 1.3.3.1

# Drug_Target_1_Theoretical_pI:
4.84

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Z19547

# Drug_Target_2_GenBank_ID_Protein:
47812

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
pyrE

# Drug_Target_2_Gene_Sequence:
>642 bp
ATGAAACCGTATCAGCGCCAGTTTATTGAGTTTGCGCTTAACAAGCAGGTACTAAAGTTT
GGCGAGTTTACGCTGAAATCCGGGCGCAAAAGCCCCTATTTCTTCAACGCCGGGCTGTTT
AATACCGGGCGCGACCTGGCGTTGTTAGGCCGTTTTTATGCCGAAGCGCTGGTGGATTCC
GGTATTGAATTTGATCTGCTGTTTGGCCCCGCGTACAAAGGTATTCCGATCGCGACGACG
ACGGCGGTTGCGCTGGCGGAACATCACGATAAAGACCTGCCGTACTGCTTTAACCGCAAA
GAGGCAAAAGATCATGGTGAAGGCGGGAGCCTGGTGGGCAGCGCGCTACAGGGCCGCGTG
ATGCTGGTGGATGACGTGATTACCGCAGGTACGGCGATTCGCGAGTCAATGGAGATTATT
CAGGCGCACGGGGCTACGCTGGCTGGCGTACTGATTTCGCTGGATCGTCAGGAACGTGGC
CGCGGCGAGATTTCCGCGATTCAGGAAGTGGAGCGCGACTATGGTTGTAAGGTTATCTCC
ATCATTACGCTGAAAGACCTGATTGCCTATCTGGAAGAAAAACCTGATATGGCTGAGCAT
CTGGCGGCTGTGCGAGCATACCGGGAAGAATTTGGCGTGTAA

# Drug_Target_2_General_Function:
Nucleotide transport and metabolism

# Drug_Target_2_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
2271660	Bhatia MB, Vinitsky A, Grubmeyer C: Kinetic mechanism of orotate phosphoribosyltransferase from Salmonella typhimurium. Biochemistry. 1990 Nov 20;29(46):10480-7.
3882417	Neuhard J, Stauning E, Kelln RA: Cloning and characterization of the pyrE gene and of PyrE::Mud1 (Ap lac) fusions from Salmonella typhimurium. Eur J Biochem. 1985 Feb 1;146(3):597-603.
7545004	Scapin G, Ozturk DH, Grubmeyer C, Sacchettini JC: The crystal structure of the orotate phosphoribosyltransferase complexed with orotate and alpha-D-5-phosphoribosyl-1-pyrophosphate. Biochemistry. 1995 Aug 29;34(34):10744-54.
7545005	Ozturk DH, Dorfman RH, Scapin G, Sacchettini JC, Grubmeyer C: Locations and functional roles of conserved lysine residues in Salmonella typhimurium orotate phosphoribosyltransferase. Biochemistry. 1995 Aug 29;34(34):10755-63.
7545006	Ozturk DH, Dorfman RH, Scapin G, Sacchettini JC, Grubmeyer C: Structure and function of Salmonella typhimurium orotate phosphoribosyltransferase: protein complementation reveals shared active sites. Biochemistry. 1995 Aug 29;34(34):10764-70.
7685580	Bhatia MB, Grubmeyer C: The role of divalent magnesium in activating the reaction catalyzed by orotate phosphoribosyltransferase. Arch Biochem Biophys. 1993 Jun;303(2):321-5.
8312245	Scapin G, Grubmeyer C, Sacchettini JC: Crystal structure of orotate phosphoribosyltransferase. Biochemistry. 1994 Feb 15;33(6):1287-94.
8376388	Grubmeyer C, Segura E, Dorfman R: Active site lysines in orotate phosphoribosyltransferase. J Biol Chem. 1993 Sep 25;268(27):20299-304.
8487307	Scapin G, Sacchettini JC, Dessen A, Bhatia M, Grubmeyer C: Primary structure and crystallization of orotate phosphoribosyltransferase from Salmonella typhimurium. J Mol Biol. 1993 Apr 20;230(4):1304-8.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2794

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
23562

# Drug_Target_2_Name:
Orotate phosphoribosyltransferase

# Drug_Target_2_Number_of_Residues:
213

# Drug_Target_2_PDB_ID:
1LH0

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_2_Protein_Sequence:
>Orotate phosphoribosyltransferase
MKPYQRQFIEFALNKQVLKFGEFTLKSGRKSPYFFNAGLFNTGRDLALLGRFYAEALVDS
GIEFDLLFGPAYKGIPIATTTAVALAEHHDKDLPYCFNRKEAKDHGEGGSLVGSALQGRV
MLVDDVITAGTAIRESMEIIQAHGATLAGVLISLDRQERGRGEISAIQEVERDYGCKVIS
IITLKDLIAYLEEKPDMAEHLAAVRAYREEFGV

# Drug_Target_2_Reaction:
orotidine 5'-phosphate + diphosphate = orotate + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Orotidine 5'-phosphate + diphosphate = orotate + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_2_SwissProt_ID:
P08870

# Drug_Target_2_SwissProt_Name:
PYRE_SALTY

# Drug_Target_2_Synonyms:
EC 2.4.2.10
OPRT
OPRTase

# Drug_Target_2_Theoretical_pI:
5.68

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Mitochondrion
mitochondrial inner membrane

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
DHODH

# Drug_Target_3_GenBank_ID_Gene:
M94065

# Drug_Target_3_GenBank_ID_Protein:
555594

# Drug_Target_3_GeneCard_ID:
DHODH

# Drug_Target_3_Gene_Name:
DHODH

# Drug_Target_3_Gene_Sequence:
>1191 bp
AAATTACCGTGGAGACACCTGCAAAAGCGGGCCCAGGATGCTGTGATCATCCTGGGGGGA
GGAGGACTTCTCTTCGCCTCCTACCTGATGGCCACGGGAGATGAGCGTTTCTATGCTGAA
CACCTGATGCCGACTCTGCAGGGGCTGCTGGACCCGGAGTCAGCCCACAGACTGGCTGTT
CGCTTCACCTCCCTGGGGCTCCTTCCACGGGCCAGATTTCAAGACTCTGACATGCTGGAA
GTGAGAGTTCTGGGCCATAAATTCCGAAATCCAGTAGGAATTGCTGCAGGATTTGACAAG
CATGGGGAAGCCGTGGACGGACTTTATAAGATGGGCTTTGGTTTTGTTGAGATAGGAAGT
GTGACTCCAAAACCTCAGGAAGGAAACCCTAGACCCAGAGTCTTCCGCCTCCCTGAGGAC
CAAGCTGTCATTAACAGGTATGGATTTAACAGTCACGGGCTTTCAGTGGTGGAACACAGG
TTACGGGCCAGACAGCAGAAGCAGGCCAAGCTCACAGAAGATGGACTGCCTCTGGGGGTC
AACTTGGGGAAGAACAAGACCTCAGTGGACGCCGCGGAGGACTACGCAGAAGGGGTGCGC
GTACTGGGCCCCCTGGCCGACTACCTGGTGGTGAATGTGTCCAGCCCCAACACTGCCGGG
CTGCGGAGCCTTCAGGGAAAGGCCGAGCTGCGCCGCCTGCTGACCAAGGTGCTGCAGGAG
AGGGATGGCTTGCGGAGAGTGCACAGGCCGGCAGTCCTGGTGAAGATCGCTCCTGACCTC
ACCAGCCAGGATAAGGAGGACATTGCCAGTGTGGTCAAAGAGTTGGGCATCGATGGGCTG
ATTGTTACGAACACCACCGTGAGTCGCCCTGCGGGCCTCCAGGGTGCCCTGCGCTCTGAA
ACAGGAGGGCTGAGTGGGAAGCCCCTCCGGGATTTATCAACTCAAACCATTCGGGAGATG
TATGCACTCACCCAAGGCCGAGTTCCCATAATTGGGGTTGGTGGTGTGAGCAGCGGGCAG
GACGCGCTGGAGAAGATCCGGGCAGGGGCCTCCCTGGTGCAGCTGTACACGGCCCTCACC
TTCTGGGGGCCACCCGTTGTGGGCAAAGTCAAGCGGGAACTGGAGGCCCTTCTGAAAGAG
CAGGGCTTTGGCGGAGTCACAGATGCCATTGGAGCAGATCATCGGAGGTGA

# Drug_Target_3_General_Function:
Nucleotide transport and metabolism

# Drug_Target_3_General_References:
1446837	Minet M, Dufour ME, Lacroute F: Cloning and sequencing of a human cDNA coding for dihydroorotate dehydrogenase by complementation of the corresponding yeast mutant. Gene. 1992 Nov 16;121(2):393-6.

# Drug_Target_3_HGNC_ID:
HGNC:2867

# Drug_Target_3_HPRD_ID:
00521

# Drug_Target_3_ID:
424

# Drug_Target_3_Locus:
16q22

# Drug_Target_3_Molecular_Weight:
42868

# Drug_Target_3_Name:
Dihydroorotate dehydrogenase, mitochondrial

# Drug_Target_3_Number_of_Residues:
395

# Drug_Target_3_PDB_ID:
1D3H

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01180	DHO_dh

# Drug_Target_3_Protein_Sequence:
>Dihydroorotate dehydrogenase, mitochondrial precursor
MAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLDPESAHRLAVR
FTSLGLLPRARFQDSDMLEVRVLGHKFRNPVGIAAGFDKHGEAVDGLYKMGFGFVEIGSV
TPKPQEGNPRPRVFRLPEDQAVINRYGFNSHGLSVVEHRLRARQQKQAKLTEDGLPLGVN
LGKNKTSVDAAEDYAEGVRVLGPLADYLVVNVSSPNTAGLRSLQGKAELRRLLTKVLQER
DGLRRVHRPAVLVKIAPDLTSQDKEDIASVVKELGIDGLIVTNTTVSRPAGLQGALRSET
GGLSGKPLRDLSTQTIREMYALTQGRVPIIGVGGVSSGQDALEKIRAGASLVQLYTALTF
WGPPVVGKVKRELEALLKEQGFGGVTDAIGADHRR

# Drug_Target_3_Reaction:
(S)-dihydroorotate + O2 = orotate + H2O2

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
Q02127

# Drug_Target_3_SwissProt_Name:
PYRD_HUMAN

# Drug_Target_3_Synonyms:
DHOdehase
Dihydroorotate dehydrogenase, mitochondrial precursor
Dihydroorotate oxidase
EC 1.3.3.1

# Drug_Target_3_Theoretical_pI:
10.23

# Drug_Target_3_Transmembrane_Regions:
13-32

# Drug_Target_4_Cellular_Location:
Cell membrane
peripheral membrane protein

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X02826

# Drug_Target_4_GenBank_ID_Protein:
42609

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
pyrD

# Drug_Target_4_Gene_Sequence:
>1011 bp
ATGTACTACCCCTTCGTTCGTAAAGCCCTTTTCCAGCTCGATCCAGAGCGCGCTCATGAG
TTTACTTTTCAGCAATTACGCCGTATTACAGGAACGCCGTTTGAAGCACTGGTGCGGCAG
AAAGTGCCTGCGAAACCTGTTAACTGCATGGGCCTGACGTTTAAAAATCCGCTTGGTCTG
GCAGCCGGTCTTGATAAAGACGGGGAGTGCATTGACGCGTTAGGCGCGATGGGATTTGGA
TCGATCGAGATCGGTACCGTCACGCCACGTCCACAGCCAGGTAATGACAAGCCGCGTCTC
TTTCGTCTGGTAGATGCCGAAGGTTTGATCAACCGTATGGGCTTTAATAATCTTGGCGTT
GATAACCTCGTAGAGAACGTAAAAAAGGCCCATTATGACGGCGTCCTGGGTATTAACATC
GGCAAAAATAAAGATACGCCAGTGGAGCAGGGCAAAGATGACTATCTGATTTGTATGGAA
AAAATCTATGCCTATGCGGGATATATCGCCATCAATATTTCATCGCCGAATACCCCAGGA
TTACGCACGCTGCAATATGGTGAAGCGCTGGATGATCTCTTAACCGCGATTAAAAATAAG
CAAAATGATTTGCAAGCGATGCACCATAAATATGTGCCGATCGCAGTGAAGATCGCGCCG
GATCTTTCTGAAGAAGAATTGATCCAGGTTGCCGATAGTTTAGTTCGCCATAATATTGAT
GGCGTTATTGCAACCAATACCACACTCGATCGTTCTCTTGTTCAGGGAATGAAAAATTGC
GATCAAACCGGTGGCTTAAGTGGTCGTCCGCTTCAGTTAAAAAGCACCGAAATTATTCGC
CGCTTGTCACTGGAATTAAACGGTCGCTTACCGATCATCGGTGTTGGCGGCATCGACTCG
GTTATCGCTGCGCGTGAAAAGATTGCTGCGGGTGCCTCACTGGTGCAAATTTATTCTGGT
TTTATTTTTAAAGGTCCGCCGCTGATTAAAGAAATCGTTACCCATATCTAA

# Drug_Target_4_General_Function:
Nucleotide transport and metabolism

# Drug_Target_4_General_References:
12220493	Norager S, Jensen KF, Bjornberg O, Larsen S: E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases. Structure. 2002 Sep;10(9):1211-23.
2992959	Larsen JN, Jensen KF: Nucleotide sequence of the pyrD gene of Escherichia coli and characterization of the flavoprotein dihydroorotate dehydrogenase. Eur J Biochem. 1985 Aug 15;151(1):59-65.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2775

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
36775

# Drug_Target_4_Name:
Dihydroorotate dehydrogenase

# Drug_Target_4_Number_of_Residues:
336

# Drug_Target_4_PDB_ID:
1F76

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01180	DHO_dh

# Drug_Target_4_Protein_Sequence:
>Dihydroorotate dehydrogenase
MYYPFVRKALFQLDPERAHEFTFQQLRRITGTPFEALVRQKVPAKPVNCMGLTFKNPLGL
AAGLDKDGECIDALGAMGFGSIEIGTVTPRPQPGNDKPRLFRLVDAEGLINRMGFNNLGV
DNLVENVKKAHYDGVLGINIGKNKDTPVEQGKDDYLICMEKIYAYAGYIAINISSPNTPG
LRTLQYGEALDDLLTAIKNKQNDLQAMHHKYVPIAVKIAPDLSEEELIQVADSLVRHNID
GVIATNTTLDRSLVQGMKNCDQTGGLSGRPLQLKSTEIIRRLSLELNGRLPIIGVGGIDS
VIAAREKIAAGASLVQIYSGFIFKGPPLIKEIVTHI

# Drug_Target_4_Reaction:
(S)-dihydroorotate + O2 = orotate + H2O2

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
(S)-dihydroorotate + O(2) = orotate + H(2)O(2)

# Drug_Target_4_SwissProt_ID:
P0A7E1

# Drug_Target_4_SwissProt_Name:
PYRD_ECOLI

# Drug_Target_4_Synonyms:
DHOD
DHODase
DHOdehase
Dihydroorotate oxidase
EC 1.3.3.1

# Drug_Target_4_Theoretical_pI:
7.97

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Cytoplasmic

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
11752352	Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
X04469

# Drug_Target_5_GenBank_ID_Protein:
42607

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
pyrC

# Drug_Target_5_Gene_Sequence:
>1047 bp
ATGACTGCACCATCCCAGGTATTAAAGATCCGCCGCCCAGACGACTGGCACCTTCACCTC
CGCGATGGCGACATGTTAAAAACTGTCGTGCCATATACCAGCGAAATTTATGGACGGGCT
ATCGTAATGCCCAATCTGGCTCCGCCCGTGACCACCGTTGAGGCTGCCGTGGCGTATCGC
CAGCGTATTCTTGACGCCGTACCTGCCGGGCACGATTTCACCCCATTGATGACCTGTTAT
TTAACAGATTCGCTGGATCCTAATGAGCTGGAGCGCGGATTTAACGAAGGCGTGTTCACC
GCTGCAAAACTTTACCCGGCAAACGCAACCACTAACTCCAGCCACGGCGTGACGTCAATT
GACGCAATCATGCCGGTACTTGAGCGCATGGAAAAAATCGGTATGCCGCTACTGGTGCAT
GGTGAAGTGACACATGCAGATATCGACATTTTTGATCGTGAAGCGCGCTTTATAGAAAGC
GTGATGGAACCTCTGCGCCAGCGCCTGACTGCGCTGAAAGTCGTTTTTGAGCACATCACC
ACCAAAGATGCTGCCGACTATGTCCGTGACGGAAATGAACGGCTGGCTGCCACCATCACT
CCGCAGCATCTGATGTTTAACCGCAACCATATGCTGGTTGGAGGCGTGCGTCCGCACCTG
TATTGTCTACCCATCCTCAAACGTAATATTCACCAACAGGCATTGCGTGAACTGGTCGCC
AGCGGTTTTAATCGAGTATTCCTCGGTACGGATTCTGCGCCACATGCACGTCATCGCAAA
GAGAGCAGTTGCGGCTGCGCGGGCTGCTTCAACGCCCCAACCGCGCTGGGCAGTTACGCT
ACCGTCTTTGAAGAAATGAATGCTTTGCAGCACTTTGAAGCATTCTGTTCTGTAAACGGC
CCGCAGTTCTATGGGTTGCCGGTCAACGACACATTCATCGAACTGGTACGTGAAGAGCAA
CAGGTTGCTGAAAGCATCGCACTGACTGATGACACGCTGGTGCCATTCCTCGCCGGGGAA
ACGGTACGCTGGTCCGTTAAACAATAA

# Drug_Target_5_General_Function:
Nucleotide transport and metabolism

# Drug_Target_5_General_References:
11401542	Thoden JB, Phillips GN Jr, Neal TM, Raushel FM, Holden HM: Molecular structure of dihydroorotase: a paradigm for catalysis through the use of a binuclear metal center. Biochemistry. 2001 Jun 19;40(24):6989-97.
1671037	Brown DC, Collins KD: Dihydroorotase from Escherichia coli. Substitution of Co(II) for the active site Zn(II). J Biol Chem. 1991 Jan 25;266(3):1597-604.
2876892	Backstrom D, Sjoberg RM, Lundberg LG: Nucleotide sequence of the structural gene for dihydroorotase of Escherichia coli K12. Eur J Biochem. 1986 Oct 1;160(1):77-82.
2885307	Wilson HR, Chan PT, Turnbough CL Jr: Nucleotide sequence and expression of the pyrC gene of Escherichia coli K-12. J Bacteriol. 1987 Jul;169(7):3051-8.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9298646	Link AJ, Robison K, Church GM: Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12. Electrophoresis. 1997 Aug;18(8):1259-313.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
2646

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
38828

# Drug_Target_5_Name:
Dihydroorotase

# Drug_Target_5_Number_of_Residues:
348

# Drug_Target_5_PDB_ID:
1XGE

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01979	Amidohydro_1

# Drug_Target_5_Protein_Sequence:
>Dihydroorotase
MTAPSQVLKIRRPDDWHLHLRDGDMLKTVVPYTSEIYGRAIVMPNLAPPVTTVEAAVAYR
QRILDAVPAGHDFTPLMTCYLTDSLDPNELERGFNEGVFTAAKLYPANATTNSSHGVTSI
DAIMPVLERMEKIGMPLLVHGEVTHADIDIFDREARFIESVMEPLRQRLTALKVVFEHIT
TKDAADYVRDGNERLAATITPQHLMFNRNHMLVGGVRPHLYCLPILKRNIHQQALRELVA
SGFNRVFLGTDSAPHARHRKESSCGCAGCFNAPTALGSYATVFEEMNALQHFEAFCSVNG
PQFYGLPVNDTFIELVREEQQVAESIALTDDTLVPFLAGETVRWSVKQ

# Drug_Target_5_Reaction:
(S)-dihydroorotate + H2O = N-carbamoyl-L-aspartate

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
(S)-dihydroorotate + H(2)O = N-carbamoyl-L- aspartate

# Drug_Target_5_SwissProt_ID:
P05020

# Drug_Target_5_SwissProt_Name:
PYRC_ECOLI

# Drug_Target_5_Synonyms:
DHOase
EC 3.5.2.3

# Drug_Target_5_Theoretical_pI:
6.14

# Drug_Target_5_Transmembrane_Regions:
None

#END_DRUGCARD DB02262
